Please note: your participation will not show as ‘Completed’ on ASHP’s website.
Your statement of participation will be saved on the Paradigm Medical Communications LLC website.
Many US states have expanded the role of pharmacists in influenza, which remains a persistent threat. Pharmacists are essential to influenza prevention and preparedness efforts, and their involvement in influenza care is consistently shown to improve outcomes. This evidence-based program will provide pharmacists with updates on best practices for identifying influenza and guiding the use of antiviral therapy, which is currently underused, even among high-risk patients who are susceptible to worse outcomes. The program will acquaint pharmacists with shifts in influenza diagnosis and care that have been prompted by the emergence of COVID-19, and the availability of a first-in-class oral antiviral agent, for which data, indications, and formulations continue to accumulate, warranting immediate practice changes in both treatment and prophylaxis.
Please note: The content for this activity is hosted on another CE Provider’s site.
Any CPE credit earned for this activity will be reported to CPE Monitor by Paradigm. Questions/Comments contact the Paradigm CME Department at (845) 398-5949 or email@example.com.